A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 26, 2019

Primary Completion Date

February 18, 2020

Study Completion Date

July 17, 2020

Conditions

Dry Eye Syndromes

Interventions

DRUG

5% GLH8NDE

5% GLH8NDE as eye drops

DRUG

Placebos

Placebo as eye drops

Trial Locations (1)

Seoul National University Hospital, Seoul